Page last updated: 2024-09-05

phosphatidylcholines and mipafox

phosphatidylcholines has been researched along with mipafox in 1 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (mipafox)	Trials (mipafox)	Recent Studies (post-2010) (mipafox)
32,204	443	5,593	107	0	13

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glynn, P; Kropp, TJ; Richardson, RJ	1

Other Studies

1 other study(ies) available for phosphatidylcholines and mipafox

Article	Year
The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry, 2004, Mar-30, Volume: 43, Issue:12 Topics: Amino Acid Sequence; Carboxylic Ester Hydrolases; Catalytic Domain; Enzyme Inhibitors; Enzyme Reactivators; Humans; Isoflurophate; Kinetics; Molecular Sequence Data; Nerve Degeneration; Organophosphorus Compounds; Phosphatidylcholines; Protons; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2004

Article

Year

The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.

Biochemistry, 2004, Mar-30, Volume: 43, Issue:12

Topics: Amino Acid Sequence; Carboxylic Ester Hydrolases; Catalytic Domain; Enzyme Inhibitors; Enzyme Reactivators; Humans; Isoflurophate; Kinetics; Molecular Sequence Data; Nerve Degeneration; Organophosphorus Compounds; Phosphatidylcholines; Protons; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2004